International Herpesvirus Workshop
国际疱疹病毒研讨会
基本信息
- 批准号:10752979
- 负责人:
- 金额:$ 0.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-07 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAnimal Disease ModelsAnimalsAntiviral AgentsAtherosclerosisAtmosphereB-LymphocytesBlindnessBooksBudgetsBurkitt LymphomaCellsChickenpoxClinical ResearchCommunitiesCongenital AbnormalityCytomegalovirusDNA biosynthesisDataDevelopmentDiseaseEducational workshopEncephalitisEnsureEnzymatic BiochemistryEyeFeesFertilizationFosteringFundingGene Expression RegulationGene Transduction AgentGenitalGenitaliaGenomeGrantHealthHerpes zoster diseaseHerpesviridaeHerpesviridae InfectionsHerpesvirus 1HumanHuman Herpesvirus 2Human Herpesvirus 4Human Herpesvirus 8ImmuneImmune EvasionImmune responseImmunologyIndividualInfectionInfectious MononucleosisInternationalKaposi SarcomaKnowledgeLaboratoriesLesionLifeMalignant NeoplasmsMedicalMembrane ProteinsMeningitisMental RetardationMicrobiologyMolecularMolecular BiologyMontanaMorbidity - disease rateNasopharynx CarcinomaNeoplasmsOralOregonParticipantPathogenesisPathogenicityPatientsPersonsPostdoctoral FellowPreventionPublishingRequest for ProposalsResearchResearch PersonnelResistance developmentRestScienceScientistSkinStructureStudentsTalentsTrainingTranscriptional RegulationTravelUlcerUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVaccinationVaccine TherapyViralViral VectorVirusWorkantiviral drug developmentcostdeafnessexperiencegene therapygraduate studentimmunosuppressedinterdisciplinary approachinterestmeetingsmortalityopportunistic pathogenorgan transplant recipientpathogenpatient populationpost-doctoral trainingpostersprofessorreactivation from latencysymposiumtherapeutic targettransmission processvaccine developmentvirus genetics
项目摘要
Project Summary
This proposal requests funds to be used to support travel and registration fees for postdoctoral fellows and
graduate students to attend the 47th International Herpesvirus Workshop (IHW) in Missoula, Montana. The IHW
is the major annual meeting for scientists studying all the herpesviruses and is very well established in its 47th
year. This meeting has been very successful, in part, because of the enthusiastic participation of the world's
leading herpesvirus researchers. The strength of the Workshop rests on the cross-fertilization that results from
comparison of different herpesviruses, different approaches to key questions and on the support and
participation of leading researchers in the field, most significantly including promising young investigators and
students in training. Moreover, the forum is truly international, with broad-based world-wide attendance. The
medical importance of this meeting is clearly indicated from the wide variety of diseases caused by the now-
recognized eight human herpesviruses. These include skin and eye ulcerations (HSV-1), genital lesions (HSV-
2), meningitis and encephalitis (HSV-1 and HSV-2), infectious mononucleosis (EBV), chicken pox and shingles
(VZV). CMV is a major cause of birth defects including mental retardation, blindness and deafness due to
congenital transmission but also a significant opportunistic pathogen in AIDS patients and organ transplant
recipients. In addition, CMV has been implicated as a pathogenic contributor in the development of
atherosclerosis. Cancer has also been associated with herpesvirus infections. EBV is associated with Burkitt's
lymphoma, other B cell neoplasias and nasopharyngeal carcinoma. The most recent human herpesvirus
discovered (HHV-8 or KSHV) is associated with Kaposi's sarcoma in AIDS patients and other
immunosuppressed persons in other groups. All of the herpesviruses persist for life and therefore pose
significant problems in the treatment of immune-compromised individuals. Diseases caused by reactivation of
most human herpesviruses are a significant cause of morbidity and mortality in various immune patient
populations. Workshop sessions will take an interdisciplinary approach to the following topics: virus structure,
mechanism of virus entry and cell-cell spread, membrane proteins, pathogenesis and latency, DNA replication,
vaccination and the immune response, transcriptional control, regulation of gene expression, chemotherapeutic
targets, and virus gene therapy.
项目概要
该提案要求资金用于支持博士后研究员的旅费和注册费以及
研究生参加在蒙大拿州米苏拉举行的第 47 届国际疱疹病毒研讨会 (IHW)。 IHW
是研究所有疱疹病毒的科学家的主要年会,已举办了 47 届
年。这次会议非常成功,部分原因在于世界各国的热情参与
领先的疱疹病毒研究人员。讲习班的力量在于相互促进
不同疱疹病毒的比较、关键问题的不同方法以及支持和支持
该领域领先研究人员的参与,最重要的是包括有前途的年轻研究人员和
学员在训练中。此外,该论坛是真正的国际性论坛,全世界都有广泛的参加者。这
现在由各种疾病引起的疾病清楚地表明了这次会议的医学重要性。
识别出八种人类疱疹病毒。这些包括皮肤和眼睛溃疡(HSV-1)、生殖器病变(HSV-
2)、脑膜炎和脑炎(HSV-1和HSV-2)、传染性单核细胞增多症(EBV)、水痘和带状疱疹
(VZV)。 CMV 是导致出生缺陷的主要原因,包括智力低下、失明和耳聋。
先天性传播,也是艾滋病患者和器官移植中重要的机会病原体
收件人。此外,CMV 被认为是疾病发展的致病因素。
动脉粥样硬化。癌症也与疱疹病毒感染有关。 EBV 与伯基特氏病有关
淋巴瘤、其他 B 细胞肿瘤和鼻咽癌。最新的人类疱疹病毒
发现(HHV-8 或 KSHV)与艾滋病患者和其他患者的卡波西肉瘤有关
其他群体中的免疫抑制者。所有疱疹病毒都会终生存在,因此构成
免疫受损个体治疗中的重大问题。重新激活引起的疾病
大多数人类疱疹病毒是各种免疫患者发病和死亡的重要原因
人口。研讨会将采用跨学科方法讨论以下主题:病毒结构、
病毒进入和细胞传播的机制、膜蛋白、发病机制和潜伏期、DNA 复制、
疫苗接种和免疫反应、转录控制、基因表达调节、化疗
靶点和病毒基因治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL N STREBLOW其他文献
DANIEL N STREBLOW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL N STREBLOW', 18)}}的其他基金
Project 2 - Novel Therapeutics for Emerging Alphavirus
项目 2 - 新兴甲病毒的新疗法
- 批准号:
10380667 - 财政年份:2019
- 资助金额:
$ 0.7万 - 项目类别:
Project 2 - Novel Therapeutics for Emerging Alphavirus
项目 2 - 新兴甲病毒的新疗法
- 批准号:
10115598 - 财政年份:2019
- 资助金额:
$ 0.7万 - 项目类别:
Project 2 - Novel Therapeutics for Emerging Alphavirus
项目 2 - 新兴甲病毒的新疗法
- 批准号:
10580024 - 财政年份:2019
- 资助金额:
$ 0.7万 - 项目类别:
HCMV US28 regulation of host cell signaling in viral latency and hematopoiesis
HCMV US28 对病毒潜伏期和造血过程中宿主细胞信号传导的调节
- 批准号:
9980283 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
HCMV US28 regulation of host cell signaling in viral latency and reactivation
HCMV US28 在病毒潜伏期和再激活过程中对宿主细胞信号传导的调节
- 批准号:
10629177 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
HCMV US28 regulation of host cell signaling in viral latency and reactivation
HCMV US28 在病毒潜伏期和再激活过程中对宿主细胞信号传导的调节
- 批准号:
10327950 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency and reactivation
人类巨细胞病毒对宿主造血祖细胞信号通路的失调调节潜伏期和重新激活
- 批准号:
10629163 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
HCMV US28 regulation of host cell signaling in viral latency and hematopoiesis
HCMV US28 对病毒潜伏期和造血过程中宿主细胞信号传导的调节
- 批准号:
10216635 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
Characterizing the Role of CMV Latency in Solid Organ Transplant Rejection
表征 CMV 潜伏期在实体器官移植排斥中的作用
- 批准号:
9220714 - 财政年份:2016
- 资助金额:
$ 0.7万 - 项目类别:
相似国自然基金
冠状动脉微血管疾病大动物模型中关键分子和心肌血流超声显像新技术研究
- 批准号:
- 批准年份:2020
- 资助金额:297 万元
- 项目类别:重点项目
视神经脊髓炎谱系疾病非人灵长类动物模型构建及表型评价
- 批准号:82071341
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
mTOR信号通路在耳蜗毛细胞发育和存活中的调控作用及其机制研究
- 批准号:81900937
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
糖脂代谢紊乱疾病灵长类动物模型构建与DNA/RNA编辑介导的基因治疗方法开发
- 批准号:91957122
- 批准年份:2019
- 资助金额:82.0 万元
- 项目类别:重大研究计划
神经退行性疾病大动物模型治疗
- 批准号:81922026
- 批准年份:2019
- 资助金额:130 万元
- 项目类别:优秀青年科学基金项目
相似海外基金
Core D -Humanized Mouse and Gene Therapy Core
Core D - 人源化小鼠和基因治疗核心
- 批准号:
10458373 - 财政年份:2022
- 资助金额:
$ 0.7万 - 项目类别:
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
内源条形码确定衰老和阿尔茨海默病中成人神经发生的复杂动态
- 批准号:
10846200 - 财政年份:2022
- 资助金额:
$ 0.7万 - 项目类别:
Core D -Humanized Mouse and Gene Therapy Core
Core D - 人源化小鼠和基因治疗核心
- 批准号:
10609766 - 财政年份:2022
- 资助金额:
$ 0.7万 - 项目类别:
Development of a universal DISC vaccine strategy against congenital cytomegalovirus
针对先天性巨细胞病毒的通用 DISC 疫苗策略的开发
- 批准号:
10595098 - 财政年份:2021
- 资助金额:
$ 0.7万 - 项目类别: